Ticarcillin/clavulanic acid

Ticarcillin/clavulanic acid
Combination of
Ticarcillin β-lactam antibiotic
Clavulanic acid β-lactamase inhibitor
Clinical data
Trade names Timentin
Routes of
administration		 Injection
Legal status
Legal status

Ticarcillin/clavulanic acid, or co-ticarclav, is a combination antibiotic consisting of ticarcillin, a β-lactam antibiotic, and clavulanic acid, a β-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against ticarcillin-resistant bacteria that produce certain β-lactamases.[1]

References

  1. ↑ GlaxoSmithKline. Date of Revision: February 7, 2014


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.